Companies / Information Technology
TER
Teradyne
Semiconductor Materials & Equipment
Semiconductor Materials & EquipmentAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health73
Growth48
Profitability70
Cash generation61
Balance sheet95
Dilution control91
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-27)69.8%Revenue growth (FY)13.1%Revenue CAGR (3y)0.4%Gross margin58.2%Operating margin20.4%Net margin17.4%Free cash flow margin14.1%R&D / revenue15.8%Stock comp / revenue2.0%Net debt / operating cash flow-0.14xCurrent ratio1.75Diluted share count change-2.2%
| Fiscal year ending | FY 2021-12 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $3.7B | $3.2B | $2.7B | $2.8B | $3.2B |
| Gross profit | $2.2B | $1.9B | $1.5B | $1.6B | $1.9B |
| Operating income | $1.2B | $832M | $501M | $594M | $650M |
| Net income | $1.0B | $716M | $449M | $542M | $554M |
| Operating cash flow | $1.1B | $578M | $585M | $672M | $674M |
| Capital expenditure | $132M | $163M | $160M | $198M | $224M |
| Free cash flow | $966M | $415M | $426M | $474M | $450M |
| R&D | $428M | $441M | $418M | $461M | $505M |
| Stock-based comp | $46M | $48M | $58M | $60M | $64M |
| Buybacks | $600M | $752M | $397M | $199M | $702M |
| Dividends | $66M | $70M | $68M | $76M | $76M |
| Cash | $1.1B | $855M | $758M | $553M | $294M |
| Total debt | — | — | — | — | $200M |
| Equity | $2.6B | $2.5B | $2.5B | $2.8B | $2.8B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.